<DOC>
	<DOC>NCT00604253</DOC>
	<brief_summary>This trial is conducted in Japan. The aim of this trial is to investigate the efficacy of insulin detemir on blood glucose control in type 2 diabetes when added to current OHA treatment.</brief_summary>
	<brief_title>Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin, beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<criteria>Duration of type 2 diabetes mellitus for at least one year Insulin naive patients OHA treatment for at least 12 weeks HbA1C between 7.510.0% Body Mass Index (BMI) below 30.0 kg/m2 Impaired renal function Impaired hepatic function Pregnant, breastfeeding (within a year after delivery), intention of becoming pregnant or not using adequate contraceptive methods</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>